We are live on ! Find out more
Bleichroeder

Bleichroeder Portfolio holdings

AUM $1.02B Turnover 33.63%
1-Year Est. Return 33%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$469M
AUM Growth
+$8.6M
Cap. Flow
-$26.5M
Cap. Flow %
-5.66%
Top 10 Hldgs %
75.59%
Holding
88
New
2
Increased
2
Reduced
7
Closed
8
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
MDXH icon
MDxHealth
MDXH
+$6.85M
2
TSVT icon
2seventy bio
TSVT
+$1.89M
3
IVAC icon
Intevac
IVAC
+$668K
4
INSM icon
Insmed
INSM
+$497K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.93%
2 Healthcare 20.73%
3 Miscellaneous 18.8%
4 Industrials 16.66%
5 Financials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$118B
$87M 18.57%
475,000
– –
2019 Q4
13 quarters
BC icon
2
Brunswick
BC
$4.63B
$80M 17.07%
975,636
– –
2020 Q1
12 quarters
LIN icon
3
Linde
LIN
$231B
$41.4M 8.84%
116,564
– –
2019 Q4
13 quarters
IVAC icon
4
DELISTED
Intevac
IVAC
$36.9M 7.88%
5,039,023
+94,918
+2% +$668K
2019 Q4
13 quarters
PROK icon
5
ProKidney
PROK
$218M
$22.6M 4.83%
2,000,000
– –
2022 Q3
2 quarters
GPGI icon
6
GPGI
GPGI
$3.76B
$22M 4.69%
3,599,298
– –
2022 Q1
4 quarters
THO icon
7
Thor Industries
THO
$3.88B
$18.1M 3.87%
227,500
– –
2020 Q1
12 quarters
CTIC
8
DELISTED
CTI BioPharma
CTIC
$16.4M 3.49%
3,893,730
– –
2021 Q4
5 quarters
INVE icon
9
INVE Technologies
INVE
$52.3M
$16M 3.42%
2,609,495
-25,000
-0.9% -$184K
2019 Q4
13 quarters
SPGI icon
10
S&P Global
SPGI
$127B
$13.8M 2.94%
40,000
– –
2019 Q4
13 quarters
MRNS icon
11
DELISTED
Marinus Pharmaceuticals
MRNS
$12.9M 2.76%
1,872,463
– –
2020 Q1
12 quarters
CORS
12
DELISTED
Corsair Partnering Corp
CORS
$12.8M 2.72%
1,250,000
– –
2021 Q3
6 quarters
DRRX icon
13
DELISTED
DURECT Corp
DRRX
$11.9M 2.55%
2,637,965
-3,498
-0.1% -$19K
2019 Q4
13 quarters
MDXH icon
14
MDxHealth
MDXH
$10.2M
$11.2M 2.39%
3,458,333
+1,500,000
+77% +$6.85M
2021 Q4
5 quarters
OPTN icon
15
DELISTED
OptiNose
OPTN
$7.81M 1.67%
269,675
– –
2021 Q4
5 quarters
BX icon
16
Blackstone
BX
$87.6B
$7.03M 1.5%
80,000
– –
2019 Q4
13 quarters
TV icon
17
Televisa
TV
$2.22B
$5.29M 1.13%
1,000,000
– –
2021 Q2
7 quarters
MIST icon
18
Milestone Pharmaceuticals
MIST
$46.2M
$5.22M 1.11%
1,326,085
– –
2021 Q4
5 quarters
IDN icon
19
Intellicheck
IDN
$33.3M
$5.18M 1.11%
2,073,583
– –
2019 Q4
13 quarters
AXP icon
20
American Express
AXP
$202B
$4.12M 0.88%
25,000
– –
2019 Q4
13 quarters
JPM icon
21
JPMorgan Chase
JPM
$825B
$3.91M 0.83%
30,000
– –
2019 Q4
13 quarters
DUOT icon
22
Duos Technologies
DUOT
$88.8M
$3.59M 0.77%
1,283,162
– –
2020 Q1
12 quarters
CUE icon
23
Cue Biopharma
CUE
$34.7M
$2.7M 0.58%
25,168
-3,541
-12% -$338K
2019 Q4
13 quarters
BRIV
24
DELISTED
B. Riley Principal 250 Merger Corp
BRIV
$2.29M 0.49%
225,000
– –
2021 Q3
6 quarters
HLTH icon
25
DELISTED
Cue Health
HLTH
$1.82M 0.39%
1,000,000
– –
2021 Q3
6 quarters

Similar funds

Bleichroeder's Q1 2023 Portfolio in Review

As of Q1 2023, Bleichroeder held 88 positions worth $469M, up 1.9% from $460M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bleichroeder withdrew a net $26.5M in Q1 2023, closing 8 positions and reducing 7 holdings. Its most notable exit was Pioneer Merger Corp, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Bleichroeder opened a new position in 2seventy bio worth $1.69M.

  • Bleichroeder's largest Q1 2023 buy was 2seventy bio: 165,407 shares worth $1.69M.
  • Bleichroeder added most to MDxHealth in Q1 2023, an estimated $6.85M increase.
  • Bleichroeder's biggest Q1 2023 reduction was Liberty Media Series C Liberty SiriusXM, cutting an estimated $6.16M.
  • Bleichroeder fully exited Pioneer Merger Corp in Q1 2023, selling an estimated $21.5M.
  • Bleichroeder's ten largest holdings make up 76% of its $469M portfolio in Q1 2023.
  • Bleichroeder opened 2 new positions and closed 8 in Q1 2023.
  • Bleichroeder's portfolio value rose 1.9% quarter-over-quarter to $469M.

Based on Bleichroeder's 13F filing for Q1 2023, filed 12 May 2023.